Login / Signup

FHL1 as a novel prognostic biomarker and correlation with immune infiltration levels in lung adenocarcinoma.

Jingtao ZhangHaitao LiMinghao GuoJing ZhangGuangming ZhangNing SunYuyuan FengWen-Qiang CuiFei Xu
Published in: Immunotherapy (2023)
Aim: We aimed to examine the effect of FHL1 in the diagnosis and prognosis of non-small-cell lung cancer and its relationship with tumor-infiltrating immune cells. Methods: FHL1 expression status and influence on clinical characteristics, diagnosis and prognosis in non-small-cell lung cancer were assessed. Interaction networks of FHL1 were revealed, and a correlation analysis between FHL1 expression and tumor immunity was performed. Results: FHL1 expression was significantly lower in tumors, and downregulated FHL1 predicted a worse prognosis for lung adenocarcinoma. FHL1 expression was correlated with tumor-infiltrating immune cells, immune checkpoints and chemokine levels. Conclusion: FHL1 is a powerful biomarker to evaluate the diagnosis and prognosis and immune infiltration level of lung adenocarcinoma.
Keyphrases
  • poor prognosis
  • binding protein
  • data analysis